Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
Recruiting · NCT05473520 · Registry updated 2026-06-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute coronary syndrome, bacterial infectious disease, cardiovascular disorder, disease, gram-positive bacterial infections, heart disorder, hypertensive disorder, lung disorder, mycobacterial infectious disease, myocardial ischemia, pulmonary hypertension, respiratory system disorder, tuberculosis, vascular disorder | Recruiting | Phase 3 | 2026-06-09 | NCT05473520 |
7 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Queen Elizabeth I | Kota Kinabalu | Malaysia | 1 |
| Klinik Kesihatan Luyang | Kota Kinabalu | Malaysia | 1 |
| Klinik Kesihatan Menggatal | Kota Kinabalu | Malaysia | 1 |
| National University Hospital | Singapore | Singapore | 8 |
| TB Control Unit | Singapore | Singapore | 1 |
| Universiti Malaysia Sabah (UMS), Borneo Medical and Health Research Centre | Kota Kinabalu | Malaysia | 1 |